WAY-118959-A

CAS No. 315703-81-2

WAY-118959-A( —— )

Catalog No. M35317 CAS No. 315703-81-2

WAY-118959-A is a potential microtubule acetylation inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 178 Get Quote
5MG 255 Get Quote
10MG 375 Get Quote
25MG 545 Get Quote
50MG 762 Get Quote
100MG 1017 Get Quote
200MG 1377 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    WAY-118959-A
  • Note
    Research use only, not for human use.
  • Brief Description
    WAY-118959-A is a potential microtubule acetylation inhibitor.
  • Description
    GM-90257 is a microtubule acetylation inhibitor that binds directly to α-tubulin. GM-90257 prevents the recruitment of α-tubulin acetyltransferase 1 (αTAT1) to the K40 residue in α-tubulin. GM-90257 causes the apoptosis of MDA-MB-231 cells with weaker effects on MCF-10A or MCF-7 cells, which have a relatively low level of microtubule acetylation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Microtubule Associated
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    315703-81-2
  • Formula Weight
    342.44
  • Molecular Formula
    C16H14N4OS2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COC1=CC=C(NC2=NC(=CS2)C2=C(C)N=C3SC=CN23)C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ahreum Kwon, et al. Potent Small-Molecule Inhibitors Targeting Acetylated Microtubules as Anticancer Agents Against Triple-Negative Breast Cancer. Biomedicines. 2020 Sep 9;8(9):338. ?
molnova catalog
related products
  • Rutaevin 7-acetate

    Rutaevin 7-acetate is a natural product for research related to life sciences.

  • MAT2A inhibitor 2

    MAT2A inhibitor 2 is a methionine adenosyltransferase 2A (MAT2A) inhibitor.?

  • NMS-P937

    NMS-P937 (NMS1286937), an oral, specific Polo-like Kinase 1 (PLK1) inhibitor, is with IC50 of 2 nM. The specificity of NMS-P937 forPLK1 is 5000-fold higher over PLK2/PLK3.